CRISPR-Cas9

Next-generation nanoparticles for precision Gene Editing

Discover how next-generation lipid nanoparticles (LNPs) are revolutionizing Gene Editing by enabling safe, precise, and efficient delivery of CRISPR and RNA-based tools.   Gene Editing is ready, and delivery is allowing translation   Gene Editing has entered the golden era. Technologies like CRISPR-Cas9, base editors, and prime editors are [...]

2025-10-30T08:29:54+00:00October 30, 2025|Blog|

How nanotechnology can overcome current limitations in Gene Editing with Viral Vectors

Gene Editing has become one of the most promising areas in modern biotechnology, offering the potential to correct genetic mutations at their source. Tools like CRISPR/Cas9, base editors, and prime editing systems are opening new therapeutic frontiers in rare diseases, oncology, and regenerative medicine. However, the delivery of these gene editing [...]

2025-05-22T07:39:02+00:00May 22, 2025|Blog|

Nanomedicine prompts the development of CRISPR-Cas9 therapies to treat hereditary angioedema

The potential of non-viral lipid delivery systems for improving global health has been proven once again. From rare diseases to cancer, gene editing and gene therapies will undoubtedly benefit from the latest advances in nanomedicine. In February 2024, the results from a promising combined phase [...]

2024-02-28T10:55:25+00:00February 28, 2024|Scientific news|
Go to Top